Continuing Nursing Education (CNE) Activity: The ABCs of Neonatal Pharmacology, Part I
Presenter(s): Jim Thigpen, PHARMD, BCPS
Total Contact Hours: 4.00 CH, 4.00 Rx
Intended Audience: All neonatal and mother baby nurses
Purpose of this CNE activity: The Academy of Neonatal Nursing provides clinically current information on the technical, medical, and nursing aspects of neonatal care as well as the legal and ethical implications related to that care. This CNE activity provides information to nurses and other health care professionals who care for newborn, premature, and ill infants and their families. Specific objectives for this presentation are listed below.
Session Description: Dr. Thigpen discusses what is new with neonatal medications, updates you on drugs currently used in the NICU, and applies this information in the presentation of practical case studies. In Part 1, he starts with A–anticoagulants and goes through L–linezolid. Drugs that are discussed include benzodiazepines, dexamethasone, erythropoietin, and ganciclovir, among others.
Objectives: Upon completion, learners will be able to:
Describe each medication, including indication, administration, mechanism of action, and common side effects.
Describe new information presented on each medication.
Identify situations where patient parameters/situation would lead to an alteration in drug therapy or special considerations.
Evaluate alternative and future pharmacotherapeutic options for application in neonates.
Requirements for Completion: The following requirements are necessary for successful completion of this CNE activity.
Access to a computer with an Internet connection
Attend/view at least 90% of the session
Complete and submit the evaluation for this CNE activity
Accreditation Provider, Academy of Neonatal Nursing, approved by the California Board of Registered Nursing, Provider #CEP 6261; and Florida Board of Nursing, Provider #FBN 3218, content code 2505.
The Academy of Neonatal Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Release Date: September 7, 2016 Expiration Date: September 30, 2019
The lead nurse planner, the planning committee, and the author(s) of this activity disclose no relevant financial relationships.
This CNE activity has been reviewed by the Lead Nurse Planner. It has been determined that the material presented here shows no bias.
The content of this CNE activity has been developed by the planning committee and reviewed by the Lead Nurse Planner. The content has been deemed to reflect the current state of practice.
Disclaimer: The Academy of Neonatal Nursing assumes no responsibility or liability for the content presented. Care of the infant should always be individualized and no one source relied upon for information regarding aspects of care. Accredited status does not imply endorsement by ANN, ANA, or the American Nurses Credentialing Center of any commercial products displayed or discussed in conjunction with an educational activity.
Associate Professor of Pharmacy Practice,
ETSU Bill Gatton College of Pharmacy